Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study
- 14 July 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 109 (9) , 872-879
Abstract
The overall natural history, risk of death and surgical burden of patients with multiple endocrine neoplasia type 1 (MEN1) is not well known. Patients with MEN1 from a nationwide cohort were included. The survival of patients with MEN1 was compared with that of the general population using simulated controls. The cumulative probabilities of MEN1-specific operations and postoperative mortality were assessed, and surgical sequences were analysed using sunburst charts and Venn diagrams. A total of 1386 patients with MEN1 were included. Life expectancy was significantly reduced in patients with MEN1 compared with simulated controls from the general population, with a lifetime difference of 15 years. Mutations affecting the JunD interaction domain had a significant negative impact on survival. Survival for patients with MEN1 compared with the general population improved over time. The probability of experiencing at least one specific MEN1 operation was above 95 per cent after 75 years, and most patients had surgery at least twice during their lifetime. Time to a 50 per cent risk of MEN1 surgery was 30.5 years for patients born after 1960, compared with 47.9 years for those born before 1960. Sex and mutations affecting the JunD interacting domain had no impact on time to first surgery. There was considerable heterogeneity in surgical sequences, with no specific clinical pathway. Life expectancy was significantly lower among patients with MEN1 compared with the general population, and further decreased in patients with mutations affecting the JunD interacting domain. Almost all patients underwent at least one MEN1-specific operation during their lifetime, but there was no standardized sequence of surgery.Keywords
This publication has 40 references indexed in Scilit:
- ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor SyndromesNeuroendocrinology, 2012
- Multiple endocrine neoplasia type 1 (MEN1)Best Practice & Research Clinical Endocrinology & Metabolism, 2010
- Pancreatectomy in Multiple Endocrine Neoplasia Type 1-Related Gastrinomas and Pancreatic Endocrine NeoplasiasAnnals of Surgery, 2006
- Outcome of Duodenopancreatic Resections in Patients With Multiple Endocrine Neoplasia Type 1Annals of Surgery, 2005
- Clinical Genetic Testing and Early Surgical Intervention in Patients With Multiple Endocrine Neoplasia Type 1 (MEN 1)Annals of Surgery, 2004
- Germline mutation profile ofMEN1in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 proteinHuman Mutation, 2002
- Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1Human Molecular Genetics, 1997
- Surgical management of insulinoma associated with multiple endocrine neoplasia type IWorld Journal of Surgery, 1994
- Findings and long‐term results of parathyroid surgery in multiple endocrine neoplasia type 1World Journal of Surgery, 1992
- Pancreatic tumors in multiple endocrine neoplasia type 1: Clinical presentation and surgical treatmentWorld Journal of Surgery, 1992